The price of life according to the HSE: €100,000 deemed ‘too expensive’ for life-saving drug for young cancer sufferer – TheLiberal.ie – Our News, Your Views

The price of life according to the HSE: €100,000 deemed ‘too expensive’ for life-saving drug for young cancer sufferer




opdivo

The crumbling HSE is refusing to fund a life-saving treatment for a 34-year-old cancer sufferer for being ‘too expensive.’

At a price tag of €100,000 per patient per year, Nivolumab (commercially known as Opdivo) may be Jacinta Kelleher’s last chance at life.

And when one compares this price tag with the over-inflated salary that’s wasted on just one TD in this country, the hypocritical cynicism of the HSE’s position becomes all too obvious.

Ms. Kelleher was diagnosed with kidney cancer three years ago, and has undergone several operations since. Cancer has already taken one of her kidneys, and the drug may be her last lifeline.

Jacinta says “It is a lot of money but at the same time, this is my life. “It is not something stupid, it is not a broken arm that you could easily fix, this will kill me and I am 34-years of age, I haven’t even begun to live my adult life yet.

“And my husband doesn’t deserve to be a widower at 34, 35 years of age.”

Share this story with a friend

Share this story

Tell us what you think on our Facebook page